COMMUNIQUÉS West-GlobeNewswire

Le Groupe Jean Coutu – Dividende quatrième trimestre de l’exercice financier 2018

01/04/2018 - 13:00

VARENNES, Québec, 01 avr. 2018 (GLOBE NEWSWIRE) -- Le Groupe Jean Coutu (PJC) inc. (la « Société » ou le « Groupe Jean Coutu ») (TSX:PJC.A) annonce que son conseil d’administration a déclaré aujourd’hui un dividende de [...]

Evogene Files Annual Report for the Year Ended December 31, 2017

01/04/2018 - 13:00

REHOVOT, Israel, April 01, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique [...]

The Jean Coutu Group – Dividend Fourth Quarter of Fiscal Year 2018

01/04/2018 - 13:00

VARENNES, Québec, April 01, 2018 (GLOBE NEWSWIRE) -- The Jean Coutu Group (PJC) Inc. (the "Corporation" or the "Jean Coutu Group") (TSX:PJC.A) announces that its Board of Directors has declared today a quarterly [...]

Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 March 2018

31/03/2018 - 12:00

Company Release no. 07/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 March 2018 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 March 2018 Veloxis Pharmaceuticals A/S [...]

Novelion Therapeutics Supports World Lipodystrophy Day

31/03/2018 - 12:00

VANCOUVER, British Columbia, March 31, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

31/03/2018 - 00:00

CAMBRIDGE, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2018

30/03/2018 - 22:18

Communiqué de presse Villepinte, le 30 mars 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

30/03/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - March 30, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

More Than 20 Cerner Executives Earn Board Certification in Health Care Management

30/03/2018 - 22:01

KANSAS CITY, Mo., March 30, 2018 (GLOBE NEWSWIRE) -- Cerner announced that 21 of its associates recently earned the distinction of board certification in health care management as Fellows of the American College of [...]

SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

30/03/2018 - 21:15

SAN RAMON, Calif., March 30, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY ), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]

Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male Osteoporosis

30/03/2018 - 20:32

WALTHAM, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that the company has initiated the Phase 3 ATOM ( A baloparatide T reatment for O steoporosis in M ales) study of [...]

NANOBIOTIX : Nanobiotix 2017 Annual Results

30/03/2018 - 16:03

Nanobiotix 2017 Annual Results Paris, France and Cambridge, Massachusetts, USA, March 30, 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to [...]

NANOBIOTIX : Nanobiotix : Résultats Annuels 2017

30/03/2018 - 16:03

Nanobiotix : Résultats Annuels 2017 Paris, France, et Cambridge, Massachusetts (USA) le 30 mars 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), société française pionnière en nanomédecine développant de [...]

Abiomed to Appoint New Chief Financial Officer Todd A. Trapp

30/03/2018 - 15:06

DANVERS, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq: ABMD ), a leading provider of breakthrough heart support technologies, today announced that Todd A. Trapp will be appointed as Vice President and [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

30/03/2018 - 14:00

BOSTON, March 30, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

NEOVACS PROVIDES CORPORATE UPDATE AND REPORTS FULL-YEAR 2017 FINANCIAL RESULTS

30/03/2018 - 07:31

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS PROVIDES CORPORATE UPDATE AND REPORTS FULL-YEAR 2017 FINANCIAL RESULTS COMPLETED PATIENT ENROLLMENT IN PHASE IIb CLINICAL STUDY OF IFNalpha KINOID FOR TREATMENT OF [...]

NÉOVACS : RÉSULTATS ANNUELS 2017 ET POINT SUR LES AVANCÉES OPÉRATIONNELLES

30/03/2018 - 07:31

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE RÉSULTATS ANNUELS 2017 ET POINT SUR LES AVANCÉES OPÉRATIONNELLES FIN DU RECRUTEMENT DES PATIENTS DANS L'ÉTUDE CLINIQUE DE PHASE IIb AVEC l'IFNalpha [...]

MedMira Reports Second Quarter Results

30/03/2018 - 01:00

HALIFAX, Nova Scotia, March 29, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2018. Profit and Loss Highlights Revenue: The Company [...]

Scythian Biosciences Announces Extension of Letter of Intent

30/03/2018 - 00:51

TORONTO, March 29, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) announced today that the Company has signed an agreement [...]